Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe

Report Says Point-of-Care Diagnostics Hasn’t Taken Off Yet

March 2, 2018 By Spencer Chin

One of the components in future medical care is point of point-of-care medicine, whereby diagnostic testing is at or near the patient’s point of care. Providing a more convenient means of providing diagnostics and monitoring promises to lower medical cost and give patients easier access to medical services.

Although the concept is gaining followers, it hasn’t exactly taken off yet, according to IVD market researcher Kalorama Information. The firm found in 2017 sales of point-of-care testing reached $19.6 billion, and expects that figure to grow a modest 4.9 percent over the next five years. The growth is lower than some estimates but 40 percent higher than the IVD market, according to Kalorama.

The firm attributes the slower growth to pricing strategies that continue to discount the cost of POC diagnostic testing in some segments but higher cost in other segments of testing.

“Good but realistically a challenging market that needs to fight for proof of utility and share,” said Bruce Carlson, publisher of Kalorama Information.  “One-time glucose testing buys, European market retrenchment, low-cost competitors driving prices.  There are other double digit estimates that have been published, but Kalorama said that its research didn’t support the level of growth except in a few markets.”

 The report noted that glucose markets are slowing because they have not been reimbursed at the levels they once were, which could be attributed to low-cost competition. The report also noted that European markets are showing lower growth as centralization is forced except when necessary.

Two promising growth areas noted in the report were FOB cancer screening and substance abuse testing.

Related Articles Read More >

An image showing the Johnson & Johnson MedTech Monarch system's controller and scope.
J&J MedTech arms its Monarch robot for futuristic lung cancer therapies
An image of the KIFFIK Lab system for ISF analysis.
Tapping into the body’s ISF ‘superhighway’ for early disease detection
An artist's rendering depicting the Vail Scientific VSNO device for rapid sepsis diagnosis.
First Look: Vail Scientific’s redesigned VSNO device for rapid sepsis screening
Brain EEG rendering from peterschreiber.media on Adobe Stock
Hidden signatures in EEGs could reduce epilepsy misdiagnoses
“mdo
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest medical device business news, application and technology trends.

DeviceTalks Weekly

See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech100 Index
  • Medical Tubing + Extrusion
  • Medical Design Sourcing
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to our E-Newsletter
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2025 WTWH Media, LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media LLC. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Supplies and Components Index
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • MedTech Resources
    • Medtech Events in 2025
    • The 2024 Medtech Big 100
    • Medical Device Handbook
    • MedTech 100 Index
    • Subscribe to Print Magazine
    • DeviceTalks
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Podcasts
    • Print Subscription
    • Webinars / Digital Events
    • Whitepapers
    • Voices
    • Video
  • 2025 Leadership
    • 2024 Winners
    • 2023 Winners
    • 2022 Winners
    • 2021 Winners
  • Women in Medtech
  • Advertise
  • Subscribe